예측 독성학용 AI 시장 : 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The AI In Predictive Toxicology Market size is expected to reach USD 6.91 Billion in 2034 from USD 0.65 Billion (2025) growing at a CAGR of 30.04% during 2026-2034.

The Global AI in Predictive Toxicology Market is experiencing rapid growth as pharmaceutical and biotechnology companies increasingly adopt artificial intelligence to evaluate chemical toxicity and drug safety. AI-driven predictive models enable faster identification of harmful compounds, reducing reliance on traditional animal testing and lengthy laboratory experiments. This shift helps companies accelerate drug discovery while improving safety assessments. As regulatory agencies encourage alternative testing methods, the demand for AI-powered toxicology platforms continues to expand across pharmaceutical, chemical, and environmental research sectors.

One of the key drivers of the market is the growing need for efficient drug development processes. AI algorithms can analyze vast datasets from genomic, molecular, and clinical studies to predict toxic responses more accurately. This significantly reduces development costs and minimizes late-stage drug failures. Additionally, increased regulatory scrutiny for chemical safety and environmental impact is encouraging industries to adopt predictive toxicology tools that can assess toxicity risks early in the development process.

Looking ahead, the market is expected to witness strong expansion as machine learning models become more sophisticated and datasets grow more comprehensive. Advancements in cloud computing and big data analytics will further enhance predictive capabilities. Collaboration between pharmaceutical companies, research institutions, and AI technology providers will drive innovation in the field. As industries continue to prioritize safer and faster product development, AI-powered predictive toxicology solutions will play a critical role in shaping the future of toxicological assessment.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

• Solution
• Services

By Technology

• Machine Learning
• Natural Language Processing
• Computer Vision
• Others

By Toxicity Endpoints

• Genotoxicity
• Hepatotoxicity
• Neurotoxicity
• Cardiotoxicity
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• Chemical & Cosmetics
• Contract Research Organizations
• Others

COMPANIES PROFILED

• Benevolent AI, Berg Health, Biovista, Celsius Therapeutics, Chemaxon Ltd, Cyclica, Exscientia PLC, Insilico Medicine, Instem plc, Lhasa Limited, Recursion Pharmaceuticals
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Machine Learning Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Natural Language Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Computer Vision Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET: BY TOXICITY ENDPOINTS 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Toxicity Endpoints
• 6.2. Genotoxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hepatotoxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Neurotoxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiotoxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Chemical & Cosmetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Component
  • 8.2.2 By Technology
  • 8.2.3 By Toxicity Endpoints
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Component
  • 8.3.2 By Technology
  • 8.3.3 By Toxicity Endpoints
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Component
  • 8.4.2 By Technology
  • 8.4.3 By Toxicity Endpoints
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Component
  • 8.5.2 By Technology
  • 8.5.3 By Toxicity Endpoints
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Component
  • 8.6.2 By Technology
  • 8.6.3 By Toxicity Endpoints
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AI IN PREDICTIVE TOXICOLOGY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Benevolent AI
  • 10.2.2 Berg Health
  • 10.2.3 Biovista
  • 10.2.4 Celsius Therapeutics
  • 10.2.5 Chemaxon Ltd
  • 10.2.6 Cyclica
  • 10.2.7 Exscientia PLC
  • 10.2.8 Insilico Medicine
  • 10.2.9 Instem Plc
  • 10.2.10 Lhasa Limited
  • 10.2.11 Recursion Pharmaceuticals